A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
Georgetown University
Georgetown University
Azienda Ospedaliero-Universitaria di Parma
Azienda Ospedaliero-Universitaria di Parma
Baylor College of Medicine
Cancer Research UK
University Health Network, Toronto
University of Heidelberg Medical Center
M.D. Anderson Cancer Center
Emory University
University of Michigan Rogel Cancer Center
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
Baylor College of Medicine
Baylor College of Medicine
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Columbia University
University of Liverpool
Case Comprehensive Cancer Center
Shenzhen University General Hospital
University Hospital Muenster
University of Colorado, Boulder
Sunnybrook Health Sciences Centre
Hospices Civils de Lyon
Northwestern University
Baylor College of Medicine
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine
Mayo Clinic
University of California, San Diego
Barbara Ann Karmanos Cancer Institute
European Association of Urology Research Foundation
University of Texas Southwestern Medical Center
City of Hope Medical Center
New York Medical College
Fudan University
University of North Carolina, Chapel Hill
Medical University of Graz